Navigation Links
Osteomesh Bioresorbable Implant for Craniofacial Surgery

ProductsOsteomesh Bioresorbable Implant for Craniofacial Surgery
Company Osteopore International
Item Osteomesh Bioresorbable Implant for Craniofacial Surgery
Features 
  • Excellent long-term clinical results
  • FDA-cleared for craniofacial indications
  • Easy handling and application
  • Mechanical properties close to human cancellous bone
  • Safe and no foreign body reaction
  • A plethora of sizes and shapes can be produced
Description Osteomesh is a bioresorbable implant used in craniofacial surgery to repair various types of fractures, like the orbital floor fracture and to fill surgical defects. It has interconnected pores which allow rapid saturation with marrow, blood and nutrients, thus providing the patients own cells with chemical signals that are required for bone growth and remodeling. The mesh is malleable and can be easily cut to any shape. The mesh offers a rigid yet flexible scaffold with sufficient mechanical strength that supports bone in-growth and it degrades as bone regeneration and remodeling takes place. Long term clinical trials showed significant bone regeneration, as the material is slowly resorbed by the body and replaced by autologous bone.
Info Osteopore International
Customer Service: +65 67758625
Web site: http://www.osteopore.com.sg/

Related medicine products :

1. Osteoplug Bioresorbable Implant for Trephination Burr Holes
2. Meridional Implant (106 Style)
3. Meridional Implant (103 Style)
4. Meridional Implant (112 Style)
5. Cylindrical Sponge Implants - 3.0 x 80 mm
6. Olk Design Sponge Implants - 5.0 x 2.5 x 80 mm
7. Olk Design Sponge Implants - 7.5 x 2.75 x 80 mm
8. Cylindrical Sponge Implants - 4.0 x 80 mm
9. Cylindrical Sponge Implants - 5.0 x 80 mm
10. Oval Sponge Implants - 5.5 x 7.5 x 80 mm
11. Oval Sponge Implants - 3.0 x 5.0 x 100 mm
Sealing Mat for 384-well PCR Plate, Natural...
Full plate covers seal all 24 MicroAmp tubes...
An alternative sealing method for samples that are stored in 96-well plates after PCR. The mat is fully autoclavable and can be reused up to 50 times....
Inquire...
Medicine Products:
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: